NOVEL 1-PHENYL-2-AMINOETHANOL DERIVATIVES OF THE FORMULA: 2-X,(R2-N(-R3)-CH(-R1)-CH(-OH)-)PHENOL ARE DISCLOSED, SOME OF WHICH HAVE STIMULANT ACTION AND SOME OF WHICH HAVE BLOCKING ACTION OF B-ADRENERGIC RECEPTORS. IN PARTICULAR PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND SELECTED FROM A1-T-BUTYLAMINOMETHYL-4-HYDROXY-M-XYLENE-A1-A3-DIOL, 4-HYDROXY-A1((P-METHOXY-AMETHYLPHENETHYL)AMINO)-METHYL) - M- XYLENE-A1,A3-DIOL AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, IN ASSOCIATION WITH A PHARMACEUTICALLY-ACCEPTABLE CARRIER ARE DISCLOSED, THE COMPOSITION BEING PREFERABLY IN DOSAGE UNIT FORM. ALSO A METHOD OF TREATING A PATIENT SUFFERING FROM BRONCHOSPASM WHICH COMPRISES ADMINISTERING AN EFFECTIVE AMOUNT OF A COMPOUND SPECIFIED.
What is the claim scope and what does the US patent landscape look like for US Patent 3,705,233?
No analysis is provided because the claim text is missing. The request only states: “The claims are:” without including the claims or their numbering. Without the actual claim language (independent and dependent claims), a complete, accurate scope and landscape analysis cannot be produced.
Key takeaways
Claim-scope analysis cannot be completed without the full claim text for US 3,705,233.
Landscape mapping (direct claim charts, design-around vectors, related family members, and contention points) requires the exact claim elements and limitations.
FAQs
Can claim scope be derived from the patent number alone?
Not to the level required for a rigorous claim-to-technology and design-around landscape.
What counts as “the claims” for a scope analysis?
The complete set of independent and dependent claim texts, including all limitations and claim numbering.
Why does landscape analysis depend on claim language?
Because patentability, infringement risk, and design-around paths hinge on the specific claim elements.
What deliverables are expected in a full landscape?
Claim element mapping, family relationship summary, and competitive/design-around analysis against relevant US filings and cited references.
What must be included to proceed?
The full text of the claims for US 3,705,233.
References
(No sources cited because the required claim text for US 3,705,233 was not provided.)
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
